CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases

CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases

To date, no curative therapy is available for the treatment of most chronic inflammatory diseases such as atopic dermatitis, rheumatoid arthritis, or autoimmune disorders. Current treatments require a lifetime supply for patients to alleviate clinical symptoms and are unable to stop the course of di...

Full description

Bibliographic Details
Main Authors: Olusiji A. Akinrinmade, Shivan Chetty, Adebukola K. Daramola, Mukit-ul Islam, Theo Thepen, Stefan Barth
Format: Article
Language:English
Published: MDPI AG 2017-09-01
Series:Biomedicines
Subjects:
CD64
immunotherapy
immunotoxins
human cytolytic fusion protein
dysregulated macrophage
chronic inflammatory disease
Online Access:https://www.mdpi.com/2227-9059/5/3/56

Similar Items

Similar Items